Quest PharmaTech Inc Cash Flow Conversion Efficiency

Latest as of October 2025: -0.002x

Quest PharmaTech Inc cash flow conversion efficiency. Based on the latest financial reports, Quest PharmaTech Inc (QPT) has a cash flow conversion efficiency ratio of -0.002x as of October 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-35.00K ≈ $-25.32K USD) by net assets (CA$23.08 Million ≈ $16.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Quest PharmaTech Inc (1998–2025)

Cash flow conversion efficiency of Quest PharmaTech Inc from 1998 to 2025. This chart illustrates how Quest PharmaTech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Quest PharmaTech Inc stock price today for real-time trading data and today's change.

Quest PharmaTech Inc Cash Flow Conversion Ratio Explained

Quest PharmaTech Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Quest PharmaTech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Quest PharmaTech Inc ranked by their cash flow conversion efficiency. Also see QPT market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Palatin Technologies Inc NYSE MKT:PTN	0.838x
Stelrad Group PLC LSE:SRAD	0.108x
BLACK PEARL ZY-10 F:7ZX	-0.011x
Nilsson Special Vehicles publ AB ST:NILS	-0.959x
Montero Mining and Exploration Ltd V:MON	-0.134x
E Tech Resources Inc V:REE	-0.023x
AE Multi Holdings Bhd KLSE:7146	0.140x
UMT United Mobility Technology AG XETRA:UMD	0.141x

Annual Cash Flow Conversion Efficiency for Quest PharmaTech Inc (1998–2025)

The table below shows the annual cash flow conversion efficiency of Quest PharmaTech Inc from 1998 to 2025. Review free cash flow generation of Quest PharmaTech Inc to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-01-31	CA$21.40 Million ≈ $15.48 Million	CA$-511.88K ≈ $-370.28K	-0.024x	-61.77%
2024-01-31	CA$23.15 Million ≈ $16.75 Million	CA$-342.42K ≈ $-247.70K	-0.015x	-121.97%
2023-01-31	CA$83.25 Million ≈ $60.22 Million	CA$-554.68K ≈ $-401.25K	-0.007x	-252.71%
2022-01-31	CA$90.41 Million ≈ $65.40 Million	CA$-170.78K ≈ $-123.54K	-0.002x	+86.84%
2021-01-31	CA$175.22 Million ≈ $126.75 Million	CA$-2.52 Million ≈ $-1.82 Million	-0.014x	-103.71%
2020-01-31	CA$-16.50 Million ≈ $-11.93 Million	CA$-6.38 Million ≈ $-4.61 Million	0.387x	-75.75%
2019-01-31	CA$-4.33 Million ≈ $-3.14 Million	CA$-6.91 Million ≈ $-5.00 Million	1.594x	+161.66%
2018-01-31	CA$2.83 Million ≈ $2.05 Million	CA$-7.33 Million ≈ $-5.30 Million	-2.584x	-496.23%
2017-01-31	CA$10.63 Million ≈ $7.69 Million	CA$-4.61 Million ≈ $-3.33 Million	-0.433x	-141.22%
2016-01-31	CA$-2.43 Million ≈ $-1.76 Million	CA$-2.56 Million ≈ $-1.85 Million	1.052x	+102.15%
2015-01-31	CA$-3.73 Million ≈ $-2.70 Million	CA$-1.94 Million ≈ $-1.41 Million	0.520x	-35.94%
2014-01-31	CA$-2.41 Million ≈ $-1.75 Million	CA$-1.96 Million ≈ $-1.42 Million	0.812x	+420.61%
1998-01-31	CA$322.79K ≈ $233.50K	CA$-81.77K ≈ $-59.15K	-0.253x	--

About Quest PharmaTech Inc

V:QPT Canada Biotechnology

Market Cap

$2.45 Million

CA$3.38 Million CAD

Market Cap Rank

#29806 Global

#1428 in Canada

Share Price

CA$0.02

Change (1 day)

+0.00%

52-Week Range

CA$0.02 - CA$0.05

All Time High

CA$0.25